" class="no-js "lang="en-US"> Partnerships Archives - Page 13 of 52 - Medtech Alert
Sunday, September 28, 2025

Sort by:

Date

Top Post

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]

Celanese Announces a Research Agreement with Johns Hopkins University to Advance Sustained Ocular Drug Delivery to the Suprachoroidal Space

Celanese Corporation, a global specialty materials and chemical company, today announced an agreement with Johns […]

Formosa Pharmaceuticals Announces Development Collaboration Agreement with Eyenovia

Taiwan-based Formosa Pharmaceuticals announced today that the company has entered into a collaboration agreement with […]

U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax' COVID-19 Vaccine

Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, […]

LegoChem Biosciences Signs License Agreement to Acquire First-in-class Antibody From Elthera

LegoChem Biosciences announced on February 13, 2023 a license agreement with Elthera AG, a biotechnology […]

Nona Biosciences Enters into HCAb Based Antibody Discovery Collaboration Agreement with Mythic Therapeutics

Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited committed to cutting-edge technology innovations, and […]

Adrestia Therapeutics Partners with Leading Patient Advocacy Groups to Form Ataxia Telangiectasia Research Consortium

Adrestia Therapeutics, a leader in synthetic rescue therapies for genetic diseases, has announced it has […]

Roche Expands Collaboration with Janssen to Advance Personalised Healthcare Through Companion Diagnostics

Roche today announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to […]

ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics

ReviR Therapeutics, a privately held developer of a suite of small molecule RNA-targeting technologies for […]

Superior HealthPlan and eFamilyCare Expand Partnership to Support Medicaid Members and Caregivers in Texas

Superior HealthPlan and eFamilyCare today announced a partnership to support family caregivers as they care […]

$25 Million Gift to Penn Medicine and Children's Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders

A $25 million gift from an anonymous donor to Penn Medicine and Children’s Hospital of […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more